{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:46:42Z","timestamp":1791906402746,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"DOI":"10.1038\/s41435-026-00407-0","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:33:35Z","timestamp":1787571215000},"page":"543-552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SERPINH1 derived from cancer-associated fibroblasts promotes epithelial-mesenchymal transition in clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"27","author":[{"given":"Ruiying","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-9664","authenticated-orcid":false,"given":"Panfeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"407_CR1","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ccell.2023.07.006","volume":"41","author":"EP Henske","year":"2023","unstructured":"Henske EP, Cheng L, Hakimi AA, Choueiri TK, Braun DA. Chromophobe renal cell carcinoma. Cancer Cell. 2023;41:1383\u20138.","journal-title":"Cancer Cell"},{"key":"407_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","volume":"16","author":"WM Linehan","year":"2019","unstructured":"Linehan WM, Ricketts CJ. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019;16:539\u201352.","journal-title":"Nat Rev Urol"},{"key":"407_CR3","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"407_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.drudis.2021.07.009","volume":"27","author":"O Pontes","year":"2022","unstructured":"Pontes O, Oliveira-Pinto S, Baltazar F, Costa M. Renal cell carcinoma therapy: current and new drug candidates. Drug Discov Today. 2022;27:304\u201314.","journal-title":"Drug Discov Today"},{"key":"407_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337.","journal-title":"Nat Med"},{"key":"407_CR6","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","volume":"184","author":"MV Plikus","year":"2021","unstructured":"Plikus MV, Wang X, Sinha S, Forte E, Thompson SM, Herzog EL, et al. Fibroblasts: origins, definitions, and functions in health and disease. Cell. 2021;184:3852\u201372.","journal-title":"Cell"},{"key":"407_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","volume":"41","author":"G Caligiuri","year":"2023","unstructured":"Caligiuri G, Tuveson DA. Activated fibroblasts in cancer: perspectives and challenges. Cancer Cell. 2023;41:434\u201349.","journal-title":"Cancer Cell"},{"key":"407_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"DZ Guo","year":"2024","unstructured":"Guo DZ, Zhang X, Zhang SQ, Zhang SY, Zhang XY, Yan JY, et al. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Mol Cancer. 2024;23:157.","journal-title":"Mol Cancer"},{"key":"407_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu W, Kang Y. Epithelial-Mesenchymal plasticity in cancer progression and metastasis. Dev Cell. 2019;49:361\u201374.","journal-title":"Dev Cell"},{"key":"407_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert AW, Weinberg RA. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat Rev Cancer. 2021;21:325\u201338.","journal-title":"Nat Rev Cancer"},{"key":"407_CR11","doi-asserted-by":"crossref","unstructured":"Asif PJ, Longobardi C, Hahne M, Medema JP. The role of cancer-associated fibroblasts in cancer invasion and metastasis. Cancers. 2021;13:4720.","DOI":"10.3390\/cancers13184720"},{"key":"407_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04303-3","volume":"21","author":"Q Ping","year":"2023","unstructured":"Ping Q, Wang C, Cheng X, Zhong Y, Yan R, Yang M, et al. TGF-beta1 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells. J Transl Med. 2023;21:475.","journal-title":"J Transl Med"},{"key":"407_CR13","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00432-018-2739-9","volume":"144","author":"BDP Duarte","year":"2018","unstructured":"Duarte BDP, Bonatto D. The heat shock protein 47 as a potential biomarker and a therapeutic agent in cancer research. J Cancer Res Clin Oncol. 2018;144:2319\u201328.","journal-title":"J Cancer Res Clin Oncol"},{"key":"407_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1755","volume":"14","author":"ES Khan","year":"2024","unstructured":"Khan ES, Dainghaus T. HSP47 in human diseases: navigating pathophysiology, diagnosis and therapy. Clin Transl Med. 2024;14:e1755.","journal-title":"Clin Transl Med"},{"key":"407_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3892\/ol.2020.12196","volume":"20","author":"K Mori","year":"2020","unstructured":"Mori K, Toiyama Y, Okugawa Y, Ichikawa T, Nagano Y, Oki S, et al. Preoperative heat shock protein 47 levels identify colorectal cancer patients with lymph node metastasis and poor prognosis. Oncol Lett. 2020;20:333.","journal-title":"Oncol Lett"},{"key":"407_CR16","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.7150\/ijbs.99734","volume":"20","author":"Y Hou","year":"2024","unstructured":"Hou Y, Zhang Y, Zheng K, Wang H, Zhou Y, Zhai Y, et al. Integrated analysis of tumor and adjacent non-tumor proteomic data reveals SERPINH1 as a recurrence biomarker and drug target in hepatocellular carcinoma. Int J Biol Sci. 2024;20:5191\u2013207.","journal-title":"Int J Biol Sci"},{"key":"407_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12931-020-01490-1","volume":"21","author":"T Miyamura","year":"2020","unstructured":"Miyamura T, Sakamoto N, Ishida K, Kakugawa T, Taniguchi H, Akiyama Y, et al. Presence of heat shock protein 47-positive fibroblasts in cancer stroma is associated with increased risk of postoperative recurrence in patients with lung cancer. Respir Res. 2020;21:234.","journal-title":"Respir Res"},{"key":"407_CR18","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1158\/0008-5472.CAN-24-0932","volume":"84","author":"H Song","year":"2024","unstructured":"Song H, Lu T, Han D, Zhang J, Gan L, Xu C, et al. YAP1 inhibition induces phenotype switching of cancer-associated fibroblasts to tumor suppressive in prostate cancer. Cancer Res. 2024;84:3728\u201342.","journal-title":"Cancer Res"},{"key":"407_CR19","doi-asserted-by":"crossref","unstructured":"Zhang Y, Narayanan SP, Mannan R, Raskind G, Wang X, Vats P, et al. Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. Proc Natl Acad Sci USA. 2021;118:e2103240118.","DOI":"10.1073\/pnas.2103240118"},{"key":"407_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114259","volume":"150","author":"H Xiao","year":"2025","unstructured":"Xiao H, Yao Z, Li T, Fang X, Xu X, Hu S, et al. SERPINH1 secretion by cancer-associated fibroblasts promotes hepatocellular carcinoma malignancy through SENP3-mediated SP1\/SQLE pathway. Int Immunopharmacol. 2025;150:114259.","journal-title":"Int Immunopharmacol"},{"key":"407_CR21","doi-asserted-by":"crossref","unstructured":"Zhou Y, Wang X, Li H, Fan M, Wang M, Gao W, et al. A positive feedback loop between SERPINH1 and MMP-9\/TGF-beta1 promotes lung adenocarcinoma progression. Cell Death Differ. 2025;33:140-55.","DOI":"10.1038\/s41418-025-01558-9"},{"key":"407_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.994","volume":"12","author":"X Pan","year":"2022","unstructured":"Pan X, Huang B, Ma Q, Ren J, Liu Y, Wang C, et al. Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. Clin Transl Med. 2022;12:e994.","journal-title":"Clin Transl Med"},{"key":"407_CR23","doi-asserted-by":"crossref","unstructured":"Derynck R, Budi EH. Specificity, versatility, and control of TGF-beta family signaling. Sci Signal. 2019;12:eaav5183.","DOI":"10.1126\/scisignal.aav5183"},{"key":"407_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41392-023-01362-2","volume":"8","author":"J Hu","year":"2023","unstructured":"Hu J, Tan P, Ishihara M, Bayley NA, Schokrpur S, Reynoso JG, et al. Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal Transduct Target Ther. 2023;8:155.","journal-title":"Signal Transduct Target Ther"},{"key":"407_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04336-8","volume":"21","author":"D Zhang","year":"2023","unstructured":"Zhang D, Ni Y, Wang Y, Feng J, Zhuang N, Li J, et al. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma. J Transl Med. 2023;21:489.","journal-title":"J Transl Med"},{"key":"407_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216234","volume":"566","author":"G Dong","year":"2023","unstructured":"Dong G, Chen P, Xu Y, Liu T, Yin R. Cancer-associated fibroblasts: key criminals of tumor pre-metastatic niche. Cancer Lett. 2023;566:216234.","journal-title":"Cancer Lett"},{"key":"407_CR27","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10555-024-10186-7","volume":"43","author":"T Guo","year":"2024","unstructured":"Guo T, Xu J. Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer Metastasis Rev. 2024;43:1095\u2013116.","journal-title":"Cancer Metastasis Rev"},{"key":"407_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11:5077.","journal-title":"Nat Commun"},{"key":"407_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"407_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41417-019-0146-2","volume":"27","author":"Q Shi","year":"2020","unstructured":"Shi Q, Xu R, Song G, Lu H, Xue D, He X, et al. GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6\/STAT3 mechanism. Cancer Gene Ther. 2020;27:726\u201338.","journal-title":"Cancer Gene Ther"},{"key":"407_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04935-1","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu H, Zhao J, Li J, Zhu Z, Cui Z, Liu R, et al. Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1alpha\/ZEB1 axis. Cell Death Dis. 2022;13:478.","journal-title":"Cell Death Dis"},{"key":"407_CR32","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/jcmm.13495","volume":"22","author":"Y Qi","year":"2018","unstructured":"Qi Y, Zhang Y, Peng Z, Wang L, Wang K, Feng D, et al. SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker. J Cell Mol Med. 2018;22:1224\u201335.","journal-title":"J Cell Mol Med"},{"key":"407_CR33","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/cas.16417","volume":"116","author":"Y Chen","year":"2025","unstructured":"Chen Y, Pan G, Yang Y, Wu H, Weng M, Wu Q, et al. Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer-associated fibroblast activation. Cancer Sci. 2025;116:792\u2013807.","journal-title":"Cancer Sci"},{"key":"407_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000520304","volume":"146","author":"W Fu","year":"2022","unstructured":"Fu W, Zhao H, Liu Y, Nie H, Gao B, Yin F, et al. Exosomes derived from cancer-associated fibroblasts regulate cell progression in clear-cell renal-cell carcinoma. Nephron. 2022;146:383\u201392.","journal-title":"Nephron"},{"key":"407_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019;18:70.","journal-title":"Mol Cancer"},{"key":"407_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0758-4","volume":"17","author":"Y Ren","year":"2018","unstructured":"Ren Y, Jia HH, Xu YQ, Zhou X, Zhao XH, Wang YF, et al. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ss1 secretion. Mol Cancer. 2018;17:5.","journal-title":"Mol Cancer"},{"key":"407_CR37","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1158\/1541-7786.MCR-21-0924","volume":"20","author":"M Yang","year":"2022","unstructured":"Yang M, Li D, Jiang Z, Li C, Ji S, Sun J, et al. TGF-beta-induced FLRT3 attenuation is essential for cancer-associated fibroblast-mediated epithelial-mesenchymal transition in colorectal cancer. Mol Cancer Res. 2022;20:1247\u201359.","journal-title":"Mol Cancer Res"},{"key":"407_CR38","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ygyno.2020.11.026","volume":"160","author":"H Yue","year":"2021","unstructured":"Yue H, Li W, Chen R, Wang J, Lu X, Li J. Stromal POSTN induced by TGF-beta1 facilitates the migration and invasion of ovarian cancer. Gynecol Oncol. 2021;160:530\u20138.","journal-title":"Gynecol Oncol"}],"container-title":["Genes & Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41435-026-00407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-026-00407-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-026-00407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:04:59Z","timestamp":1791903899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-026-00407-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1038\/s41435-026-00407-0","relation":{},"ISSN":["1476-5470"],"issn-type":[{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Ethics Committee of The Second Hospital & Clinical Medical School, Lanzhou University, approval number: (2025A-529), approval date: 2025-4-27. All animal research protocols were approved by The Second Hospital & Clinical Medical School, Lanzhou University Animal Care Committee, approval number: (D2025-393), approval date: 2025-4-14.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}